B RILEY FINANCIAL INC - RILY 6 3/8 02/28/25 (RILYM)

US05580M8689

20.5  -0.14 (-0.68%)

Fundamental Rating

2

Overall RILYM gets a fundamental rating of 2 out of 10. We evaluated RILYM against 219 industry peers in the Capital Markets industry. Both the profitability and financial health of RILYM have multiple concerns. RILYM does not seem to be growing, but still is valued expensively.



2

1. Profitability

1.1 Basic Checks

RILYM had negative earnings in the past year.
In the past year RILYM had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: RILYM reported negative net income in multiple years.
Of the past 5 years RILYM 4 years had a positive operating cash flow.

1.2 Ratios

RILYM has a worse Return On Assets (-3.49%) than 89.30% of its industry peers.
RILYM has a worse Return On Equity (-76.26%) than 95.35% of its industry peers.
RILYM's Return On Invested Capital of 1.95% is on the low side compared to the rest of the industry. RILYM is outperformed by 73.02% of its industry peers.
Industry RankSector Rank
ROA -3.49%
ROE -76.26%
ROIC 1.95%
ROA(3y)0.98%
ROA(5y)2.8%
ROE(3y)-2.83%
ROE(5y)10.63%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Operating Margin of RILYM (8.23%) is worse than 77.21% of its industry peers.
RILYM's Operating Margin has declined in the last couple of years.
RILYM's Gross Margin of 67.58% is fine compared to the rest of the industry. RILYM outperforms 66.98% of its industry peers.
RILYM's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 8.23%
PM (TTM) N/A
GM 67.58%
OM growth 3Y-31.23%
OM growth 5Y-5.04%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.85%
GM growth 5Y-5.38%

0

2. Health

2.1 Basic Checks

Compared to 1 year ago, RILYM has more shares outstanding
Compared to 5 years ago, RILYM has more shares outstanding
Compared to 1 year ago, RILYM has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -0.12, we must say that RILYM is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of RILYM (-0.12) is worse than 80.47% of its industry peers.
RILYM has a debt to FCF ratio of 42.28. This is a negative value and a sign of low solvency as RILYM would need 42.28 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 42.28, RILYM is doing worse than 61.86% of the companies in the same industry.
A Debt/Equity ratio of 18.53 is on the high side and indicates that RILYM has dependencies on debt financing.
The Debt to Equity ratio of RILYM (18.53) is worse than 96.28% of its industry peers.
Industry RankSector Rank
Debt/Equity 18.53
Debt/FCF 42.28
Altman-Z -0.12
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 0.22 indicates that RILYM may have some problems paying its short term obligations.
The Current ratio of RILYM (0.22) is worse than 89.77% of its industry peers.
RILYM has a Quick Ratio of 0.22. This is a bad value and indicates that RILYM is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.18, RILYM is doing worse than 92.56% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.22
Quick Ratio 0.18

3

3. Growth

3.1 Past

RILYM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -11.84%.
Looking at the last year, RILYM shows a very strong growth in Revenue. The Revenue has grown by 31.31%.
Measured over the past years, RILYM shows a very strong growth in Revenue. The Revenue has been growing by 28.48% on average per year.
EPS 1Y (TTM)-11.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-434.63%
Revenue 1Y (TTM)31.31%
Revenue growth 3Y18.88%
Revenue growth 5Y28.48%
Sales Q2Q%-15.01%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

2

4. Valuation

4.1 Price/Earnings Ratio

RILYM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of RILYM indicates a somewhat cheap valuation: RILYM is cheaper than 73.02% of the companies listed in the same industry.
RILYM's Price/Free Cash Flow ratio is rather cheap when compared to the industry. RILYM is cheaper than 80.93% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.2
EV/EBITDA 16.03

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 32.21%, RILYM is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 8.61, RILYM pays a better dividend. On top of this RILYM pays more dividend than 98.60% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.26, RILYM pays a better dividend.
Industry RankSector Rank
Dividend Yield 32.21%

5.2 History

The dividend of RILYM is nicely growing with an annual growth rate of 43.04%!
RILYM has paid a dividend for less than 5 years, so there is no long track record yet.
RILYM has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)43.04%
Div Incr Years0
Div Non Decr Years3

5.3 Sustainability

The earnings of RILYM are negative and hence is the payout ratio. RILYM will probably not be able to sustain this dividend level.
DP-67.91%
EPS Next 2YN/A
EPS Next 3YN/A

B RILEY FINANCIAL INC - RILY 6 3/8 02/28/25

NASDAQ:RILYM (9/19/2024, 4:30:01 PM)

20.5

-0.14 (-0.68%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap621.15M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 32.21%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.49%
ROE -76.26%
ROCE
ROIC
ROICexc
ROICexgc
OM 8.23%
PM (TTM) N/A
GM 67.58%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 18.53
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.22
Quick Ratio 0.18
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-11.84%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)31.31%
Revenue growth 3Y18.88%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y